AppCorpus
Market US

Davis's Drug Guide - Nurses

A medication guide for nurses

by Unbound Medicine, Inc.

iPhone · iPad

Active Last checked 31 Jul 2026

Quick verdict

What it is
The app provides access to a comprehensive drug guide, including monographs, audio pronunciations, pill images, and dosing calculators. It also includes features such as critical safety alerts, highlighted Risk Evaluation and Mitigation Strategies (REMS), and pharmacology indexes.
Best for
  • nursing students
  • practicing nurses
  • physicians
  • pharmacists
At a glance
  • Free to download
  • In-app purchases

Categories and search queries

Official categories

AppCorpus categories

Key functions

Function Availability Access Scope Evidence
Free app Yes Free Store published
In-app purchases Yes Limited free Store published

Screens

No screenshots collected yet.

Pricing & paywalls

App Store

  • Free to download
  • In-app purchases

Ratings & reviews

App Store

4.9 9092 ratings · App Store

  1. 5/5Awesome Drug Reference for Nurses

    I literally use my Davis Drug Guide everyday at work. The hospital I work at is small, so we (the nurses) mix all the medications that don’t come premixed. This app lists how to reconstitute and dilute the medication. There have been very few times I haven’t been able to find how to prepare a medication on this app. This app is also very helpful for checking IV compatibility between different medications. It lists the compatible meds and the incompatible meds for each drug. The list of side effects and adverse reactions is very helpful as well. Another of my favorite things on the app is the wide range of calculators on the app. There have been many times a coworker and I are calculation infusion rates for critical meds and I often use the calculators on this app to double check our math. I recommend this app all the time to my coworkers.

    Autism4Life92 · 31 Jul 2026

  2. 5/5Worth the money

    I purchased this app for $40 and now when my operating system with apple just updated, the app quit working. The developers told me that they are not going to be updating the app and the only solution is for me to purchase the app again. No thank you. So unless you want to keep buying this whenever your OS updates, don’t get it. *UPDATE* Customer service gave me a very easy fix. I am so happy because I really love this app. I’m a nurse and use it frequently. Highly recommend.

    JJ1963 · 31 Jul 2026

  3. 5/5Great for nursing students!

    This app is great for nursing students! It’s a must have even if it’s not recommended by your nursing program. I have found it extremely beneficial to have right in my pocket at clinical, completing homework, and hopefully one day accepting a RN position as a new grad. All adverse reactions that are life threatening are in red and capitalized, all adverse reactions that are common with a certain drug are underlined. It has been a great tool for my success, highly recommended!

    MeghanG1724 · 31 Jul 2026

  4. 5/5Great app

    I had the old version of the drug guide which didn’t work with the new iOS. I received instructions from this company on how to download the latest version that would immediately, and they resolved the issue in less than 24 hours. This is a great app. I’m a nurse and I love to be able to check unfamiliar meds and potential side effects quickly. This is my go-to app at work and very user friendly. Highly recommend it!

    Superbunny1982 · 31 Jul 2026

  5. 5/5Nurse

    I wish this app was a little more user friendly, often times I am referencing things on the fly and I need to check details quickly and efficiently. This so is not easy to check details if you do not have spelling exactly correct. I would like to see the search be more predictive or options for phonetic spelling. To show multiple options so confusion would be avoided.

    User987Unhappy · 31 Jul 2026

Privacy & accessibility

App Store

Privacy

  • Data Linked to You — Analytics — Identifiers — User ID Developer declared
  • Data Linked to You — Analytics — Search History Developer declared
  • Data Linked to You — Analytics — Usage Data — Product Interaction Developer declared
  • Data Linked to You — App Functionality — Identifiers — User ID Developer declared
  • Data Linked to You — App Functionality — Search History Developer declared
  • Data Linked to You — App Functionality — Usage Data — Product Interaction Developer declared
  • Data Linked to You — Developer’s Advertising or Marketing — Contact Info — Email Address Developer declared
  • Data Linked to You — Developer’s Advertising or Marketing — Contact Info — Name Developer declared
  • Data Linked to You — Developer’s Advertising or Marketing — Identifiers — User ID Developer declared
  • Data Linked to You — Developer’s Advertising or Marketing — Usage Data — Product Interaction Developer declared
  • Data Linked to You — Product Personalization — Identifiers — User ID Developer declared
  • Data Linked to You — Product Personalization — Search History Developer declared
  • Data Linked to You — Product Personalization — Usage Data — Product Interaction Developer declared
  • Data Linked to You — Contact Info Developer declared
  • Data Linked to You — Identifiers Developer declared
  • Data Linked to You — Search History Developer declared
  • Data Linked to You — Usage Data Developer declared

Accessibility

No accessibility labels collected yet.

Versions

App Store

  • 1.38

    - Quarterly content update with 179 new and revised topics - Bug Fixes Questions about Davis's Drug Guide? Please contact Unbound Medicine Support.

  • 1.39

    - Bug Fixes Questions about Davis's Drug Guide? Please contact Unbound Medicine Support.

  • 1.40

    - Option to add Drug Interactions from The Medical Letter to your Davis's Drug Guide subscription Questions about Davis's Drug Guide? Please contact Unbound Medicine Support.

  • 1.41

    - Content Update: Includes all content from New 18th edition published in June 2022 - New app icons and banner - Supports larger font sizes in-app. Questions about Davis's Drug Guide? Please contact Unbound Medicine Support.

  • 1.42

    - 14-day free trial - Quarterly content Update - Bug fixes Questions about Davis's Drug Guide? Please contact Unbound Medicine Support.

  • 1.43

    - Bug fixes Questions about Davis's Drug Guide? Please contact Unbound Medicine Support.

  • 1.44

    • Includes EXCLUSIVE DrugGuide.com access. • 200+ NEW and UPDATED drug monographs added. EXAMPLES: -- nirmatrelvir/ritonavir (Paxlovid) -- lecanemab (Leqembi) -- tirzepatide (Mounjaro) -- semiglutide (Rybelsus, Ozempic, Wegovy) -- inclisiran (Leqvio) -- brocitinib (Cibinqo) -- faricimab (Vabysmo) -- zuranolone (Zulresso) -- molnupiravir (Lagevrio) See "What's New" in the App to explore the entire list.

  • 1.45

    • Includes EXCLUSIVE DrugGuide.com access. • New Notes design • Improved search • 200+ NEW and UPDATED drug monographs added. EXAMPLES: -- nirmatrelvir/ritonavir (Paxlovid) -- lecanemab (Leqembi) -- tirzepatide (Mounjaro) -- semiglutide (Rybelsus, Ozempic, Wegovy) -- inclisiran (Leqvio) -- brocitinib (Cibinqo) -- faricimab (Vabysmo) -- zuranolone (Zulresso) -- molnupiravir (Lagevrio) See "What's New" in the App to explore the entire list.

  • 1.46

    This update includes the quarterly update with dozens of new and updated drugs. Visit the "What's New" entry in the app to explore the entire list. Please contact Unbound Medicine Support with any questions or feedback.

  • 1.47

    Now includes 19th Edition (May 2024) content. Visit the "What's New" entry in the app to explore the entire list of new and updated drugs. Updates include: * All monographs have been rigorously reviewed to include the most up-to-date information, new, FDA-approved drugs, and drugs approved for use in Canada. * Adverse side effects are now listed in order of most frequent, life threatening and frequent, life threatening, and other side effects. * A more streamlined presentation of the nursing implementation and family teaching sections of the monographs. * Now includes Routine Pediatric and Adult Immunizations appendix which incorporates the most recent recommendations. * Integrated the 2023 BEERS criteria from the American Geriatrics Society reflects the latest information on potentially inappropriate medication use in older adults. Please contact Unbound Medicine Support with any questions or feedback.

  • 1.48

    Now includes 19th Edition (May 2024) content. Visit the "What's New" entry in the app to explore the entire list of new and updated drugs. Updates include: * All monographs have been rigorously reviewed to include the most up-to-date information, new, FDA-approved drugs, and drugs approved for use in Canada. * Adverse side effects are now listed in order of most frequent, life threatening and frequent, life threatening, and other side effects. * A more streamlined presentation of the nursing implementation and family teaching sections of the monographs. * Now includes Routine Pediatric and Adult Immunizations appendix which incorporates the most recent recommendations. * Integrated the 2023 BEERS criteria from the American Geriatrics Society reflects the latest information on potentially inappropriate medication use in older adults. Please contact Unbound Medicine Support with any questions or feedback.

  • 1.49

    Updated branding and improvements to optimize performance. Please contact Unbound Medicine Support with any questions or feedback.

  • 1.50

    Improvements to help optimize performance. Please contact Unbound Medicine Support with any questions or feedback.

  • 1.51

    Further improvements to help optimize performance. Please contact Unbound Medicine Support with any questions or feedback.

  • 1.52

    Improvements to help optimize performance. Please contact Unbound Medicine Support with any questions or feedback.

  • 1.53

    * Latest FDA approvals & clinical uses * App improvements to optimize performance Please contact Unbound Medicine Support with any questions or feedback.

  • 1.54

    * Latest FDA approvals & clinical uses * App improvements to optimize performance Please contact Unbound Medicine Support with any questions or feedback.

  • 1.55

    * Updated to optimize changes to the latest operating system (iOS 26) including liquid glass display * Latest FDA approvals & clinical uses Please contact Unbound Medicine Support with any questions or feedback.

  • 1.56

    * Bug fix related to changes to the latest operating system (iOS 26) Please contact Unbound Medicine Support with any questions or feedback.

  • 1.57

    * Quarterly content update: Now featuring 29 new drugs and over 600 updated monographs. For a complete list of updates, please see the "What's New" section in the "All Topics" index. * Bug fix related to changes to the latest operating system (iOS 26). Please contact Unbound Medicine Support with any questions or feedback.

  • 1.58

    This update includes bug fixes and enhancements for compatibility with the latest iOS. Additionally, we have improved the Favorites tab view, particularly when closing and reopening the app on iPad. If you have any questions or feedback, please contact Unbound Support.

  • 1.59

    Updated the app information to be in compliance with the latest regulatory changes.

  • 1.60

    We’ve upgraded our purchase process. We implemented Apple’s latest payment technology to make buying and restoring purchases smoother than ever. - Instant Access: Your premium features unlock immediately after purchase. - Better Reliability: No more "Restore Purchase" errors. - Seamless Management: Easier control over your subscription status directly within the app If you have any questions or feedback, please contact Unbound Medicine Support.

  • 1.61

    * Now updated for the 2027-2028 (20th) edition, featuring: - Dozens of new FDA-approved drugs - Hundreds of comprehensively revised monographs - A fully updated gallery of pill images - New app icon to reflect latest branding

  • 1.62 · 1 Jun 2026

    * In this update, we've improved the performance of our built-in calculators, ensuring you get fast, dependable results.

Alternatives

Availability by market

Data quality & evidence

Page completeness
Independent summary published
Last verified
31 Jul 2026
Sources
App Store

Report a correction